drugset / Trial / NCT03414268

Micronized dHACM Injectable for the Treatment of Plantar Fasciitis

NCT03414268 ↗

Phase 3 Completed 208 enrolled MiMedx Group, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

Prospective, double-blinded, randomized controlled trial of the micronized dHACM injection as compared to the saline placebo injection in the treatment of plantar fasciitis

Timeline

Start
2018-01-08
Primary completion
2021-03-17
Completion
2021-03-17

Drugs

EvaluationDrugModalityDoseRoute
Subject dHACM Other / unclassified 40 mg Other

Indications